KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Average (2016 - 2025)

Quest Diagnostics' Equity Average history spans 17 years, with the latest figure at $7.3 billion for Q4 2025.

  • For Q4 2025, Equity Average rose 6.2% year-over-year to $7.3 billion; the TTM value through Dec 2025 reached $7.3 billion, up 6.2%, while the annual FY2025 figure was $7.0 billion, 6.57% up from the prior year.
  • Equity Average for Q4 2025 was $7.3 billion at Quest Diagnostics, roughly flat from $7.3 billion in the prior quarter.
  • Across five years, Equity Average topped out at $7.3 billion in Q3 2025 and bottomed at $6.0 billion in Q1 2023.
  • The 5-year median for Equity Average is $6.4 billion (2022), against an average of $6.6 billion.
  • The largest annual shift saw Equity Average grew 19.39% in 2021 before it decreased 6.82% in 2023.
  • A 5-year view of Equity Average shows it stood at $6.5 billion in 2021, then fell by 5.52% to $6.1 billion in 2022, then rose by 4.94% to $6.4 billion in 2023, then rose by 6.63% to $6.8 billion in 2024, then rose by 6.2% to $7.3 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Equity Average are $7.3 billion (Q4 2025), $7.3 billion (Q3 2025), and $7.1 billion (Q2 2025).